Objectives Treatment options for preventing vaso-occlusive crises (VOC) among patients with sickle cell disease (SCD) are limited, especially if hydroxyurea treatment has failed or is contraindicated.

ZURICH, March 24 (Reuters) - Swiss construction chemicals maker Sika's annual results could trend towards the ‌lower end of its outlook due to turbulence linked to the Middle East conflict, CEO Thomas ...

Sika is the market leader in the highly fragmented construction chemicals sector. Established in 1910 following the invention of a waterproofing admixture for mortar, regular product innovations ...